Mittie Doyle, Chief Medical Officer at Avalo Therapeutics, Inc. (AVTX), sold 50,984 shares at $16.15 ($823K) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Open-market sale of $823k AVTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.15 | 25,492 | $412K | 50.0% |
| 2 | $16.15 | 25,492 | $412K | 50.0% |
| Total | $16.15 avg | 50,984 | $823K | 100% |
| Filing → |
| AVTX | SELL | 2026-08-12 | $14K | — | Filing → |
| AVTX | SELL | 2026-07-29 | $20K | — | Filing → |
| AVTX | SELL | 2026-07-02 | $93K | — | Filing → |